» Authors » Christopher D Nielsen

Christopher D Nielsen

Explore the profile of Christopher D Nielsen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 258
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fudim M, Borlaug B, Mohan R, Price M, Fail P, Goyal P, et al.
JAMA Cardiol . 2024 Oct; 9(12):1143-1153. PMID: 39356530
Importance: Greater splanchnic nerve ablation may improve hemodynamics in patients with heart failure and preserved ejection fraction (HFpEF). Objective: To explore the feasibility and safety of endovascular right-sided splanchnic nerve...
2.
Kachel M, Melo P, Van Wygerden K, Cheng Y, Corcoran M, Garlick D, et al.
J Cardiol . 2023 Sep; 83(3):184-190. PMID: 37684005
Background: As the catheter-based device closure of the patent foramen ovale (PFO) is expanding, novel devices aim to address the limitations of first-generation occluders (e.g. bulk, erosion, dislodgment). The second-generation...
3.
Hennawi H, Mathbout M, Bidwell K, Nielsen C
Glob Cardiol Sci Pract . 2022 Nov; 2022(1-2):e202209. PMID: 36339676
A 40-year-old male patient with no significant medical history was admitted with an inferior ST-segment elevation myocardial infarction. Primary percutaneous coronary intervention revealed a right coronary artery aneurysm, with no...
4.
Hennawi H, Mathbout M, Taftafa A, Nielsen C
Glob Cardiol Sci Pract . 2022 Nov; 2022(1-2):e202210. PMID: 36339669
While coronary artery disease involving the septal perforator branches presents similar to diseases of major coronary arteries, management can present a challenge. Owing to their relatively small size, performing interventional...
5.
Fernandes V, Karimianpour A, Rier J, Shaji S, Mullinax B, Wahlquist A, et al.
J Invasive Cardiol . 2021 Sep; 33(10):E769-E776. PMID: 34559674
Background: Alcohol septal ablation (ASA) is an accepted treatment for medically refractory hypertrophic obstructive cardiomyopathy (HOCM). The procedural and medium-term outcomes have been reassuring. The iatrogenic targeted septal infarction has...
6.
Karimianpour A, Heizer J, Leaphart D, Rier J, Shaji S, Ramakrishnan V, et al.
Catheter Cardiovasc Interv . 2021 Jan; 98(2):393-400. PMID: 33491861
Background: Alcohol septal ablation (ASA) is a proven method of septal reduction for patients with drug refractory, symptomatic hypertrophic obstructive cardiomyopathy (HOCM). This procedure is associated with a 6.5-11% risk...
7.
Viray M, Bonno E, Gabrielle N, Maron B, Atkins J, Amoroso N, et al.
Circ Heart Fail . 2020 Oct; 13(11):e007981. PMID: 33016102
No abstract available.
8.
Houston B, Tedford R, Baxley R, Sykes B, Powers E, Nielsen C, et al.
Am J Cardiol . 2019 Jul; 124(5):756-762. PMID: 31296367
Lymphatic flow is augmented in states of chronic heart failure (cHF). However, the biological mechanism driving increased lymphatic flow capacity (lymphangiogenesis) in cHF is unknown. Recent studies have indicated that...
9.
Feldman T, Mauri L, Kahwash R, Litwin S, Ricciardi M, van der Harst P, et al.
Circulation . 2017 Nov; 137(4):364-375. PMID: 29142012
Background: In nonrandomized, open-label studies, a transcatheter interatrial shunt device (IASD, Corvia Medical) was associated with lower pulmonary capillary wedge pressure (PCWP), fewer symptoms, and greater quality of life and...
10.
Leonardi R, Townsend J, Patel C, Wolf B, Todoran T, Fernandes V, et al.
Cardiovasc Revasc Med . 2013 Jul; 14(4):218-22. PMID: 23886870
Background: Fractional flow reserve (FFR), the hyperemic ratio of distal (Pd) to proximal (Pa) coronary pressure, is used to identify the need for coronary revascularization. Changes in left ventricular end-diastolic...